3,526
Participants
Start Date
February 28, 2005
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Atazanavir
300 mg taken orally once daily
Didanosine
400 mg taken orally once daily
Efavirenz
600 mg taken orally once daily
Emtricitabine/Tenofovir disoproxil fumarate
200 mg emtricitabine/ 300 mg tenofovir disoproxil fumarate tablet taken orally once daily
Lamivudine
300 mg taken orally once daily
Lopinavir/Ritonavir
200 mg lopinavir/ 50 mg ritonavir tablet taken orally once daily
Nevirapine
200 mg taken orally once daily for 14 days followed by 200 mg taken orally twice daily
Stavudine
Dosage depends on weight
Tenofovir disoproxil fumarate
300 mg taken orally once daily
Zidovudine/Lamivudine
150 mg lamivudine/ 300 mg zidovudine tablet taken orally twice daily
Soweto HPTN CRS, Johannesburg
Wits Helen Joseph Hospital CRS (Wits HJH CRS), Johannesburg
Kisumu Crs, Kisumu
CMU HIV Prevention CRS, Chiang Mai
NARI Clinic at Gadikhana Dr. Kotnis Municipal Dispensary CRS, Pune
NARI Clinic at NIV CRS, Pune
NARI Pune CRS, Pune
Chennai Antiviral Research and Treatment (CART) CRS, Chennai
Fenway Community Health Ctr. CRS, Boston
Gaborone CRS, Gaborone
Blantyre CRS, Blantyre
Malawi CRS, Lilongwe
Parirenyatwa CRS, Harare
Hospital Geral de Nova Iguaçu CRS (HGNI CRS), Nova Iguaçu
Hospital Nossa Senhora da Conceicao CRS, Port Alegre
HSE-Hospital dos Servidores do Estado CRS, Rio de Janeiro
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro
HIV Prevention Trials Network
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH